파킨슨병 환자에서 위장관 운동조절제의 사용현황 및 처방에 미치는 요인

Gastrointestinal motility drugs have been prescribed to manage functional dyspepsia in Parkinson’s disease(PD). However, anti-dopaminergic gastrointestinal motility drugs can exacerbate motor symptoms of PD. This studyinvestigated the current use and factors affecting prescription of gastrointestina...

Full description

Saved in:
Bibliographic Details
Published inYaghag-hoi-ji Vol. 63; no. 6; pp. 333 - 344
Main Author 이창훈(Chang Hoon Lee), 김시인(Siin Kim), 서혜선(Hae Sun Suh)
Format Journal Article
LanguageKorean
Published The Pharmaceutical Society Of Korea 30.12.2019
대한약학회
Subjects
Online AccessGet full text
ISSN0377-9556
2383-9457
DOI10.17480/psk.2019.63.6.333

Cover

Abstract Gastrointestinal motility drugs have been prescribed to manage functional dyspepsia in Parkinson’s disease(PD). However, anti-dopaminergic gastrointestinal motility drugs can exacerbate motor symptoms of PD. This studyinvestigated the current use and factors affecting prescription of gastrointestinal motility drugs in PD patients. Thisretrospective cohort study extracted 3 patient groups (high-risk anti-dopaminergic drugs, low-risk anti-dopaminergic drugsand trimebutine group), by using the National Health Insurance Service-National Sample Cohort database. The mostfrequently prescribed drug was domperidone (n=437). Age and Charlson comorbidity index (CCI) were significantlydifferent across three patient groups (p-value<0.05). Post hoc test (Tukey test) showed that high-risk group and trimebutinegroup were significantly different in age and CCI (p-value<0.05). The chi-square test for types of institution and clinicaldepartments were significantly different across patient groups (p-value<0.001). Compared to tertiary hospital, generalhospital [odds ratio (OR): 2.05, confidence interval (CI): 1.07-3.93], hospital/psychiatric hospital (OR: 4.28 CI: 2.11-8.65),and clinic (OR: 4.94 CI: 2.64-9.26) were more likely to prescribe high-risk drugs than low-risk drugs. Among clinicaldepartments, neurology (OR: 0.08 CI: 0.05-0.14) was less likely to prescribe high-risk drugs than low-risk drugs. Whencomparing low-risk drugs group and trimebutine group, low-risk drugs were less likely to be prescribed in general hospital(OR: 0.40 CI: 0.18-0.92), hospital/psychiatric hospital (OR: 0.24 CI: 0.10-0.58), and clinic (OR: 0.16 CI: 0.08-0.36) thanin tertiary hospital; Neurology (OR: 20.38 CI: 9.65-43.06) was more likely to prescribe low-risk drugs. Consequently,tertiary hospital and neurology were more likely to prescribe low-risk drugs than clinics and internal medicine, respectively. KCI Citation Count: 0
AbstractList Gastrointestinal motility drugs have been prescribed to manage functional dyspepsia in Parkinson’s disease(PD). However, anti-dopaminergic gastrointestinal motility drugs can exacerbate motor symptoms of PD. This studyinvestigated the current use and factors affecting prescription of gastrointestinal motility drugs in PD patients. Thisretrospective cohort study extracted 3 patient groups (high-risk anti-dopaminergic drugs, low-risk anti-dopaminergic drugsand trimebutine group), by using the National Health Insurance Service-National Sample Cohort database. The mostfrequently prescribed drug was domperidone (n=437). Age and Charlson comorbidity index (CCI) were significantlydifferent across three patient groups (p-value<0.05). Post hoc test (Tukey test) showed that high-risk group and trimebutinegroup were significantly different in age and CCI (p-value<0.05). The chi-square test for types of institution and clinicaldepartments were significantly different across patient groups (p-value<0.001). Compared to tertiary hospital, generalhospital [odds ratio (OR): 2.05, confidence interval (CI): 1.07-3.93], hospital/psychiatric hospital (OR: 4.28 CI: 2.11-8.65),and clinic (OR: 4.94 CI: 2.64-9.26) were more likely to prescribe high-risk drugs than low-risk drugs. Among clinicaldepartments, neurology (OR: 0.08 CI: 0.05-0.14) was less likely to prescribe high-risk drugs than low-risk drugs. Whencomparing low-risk drugs group and trimebutine group, low-risk drugs were less likely to be prescribed in general hospital(OR: 0.40 CI: 0.18-0.92), hospital/psychiatric hospital (OR: 0.24 CI: 0.10-0.58), and clinic (OR: 0.16 CI: 0.08-0.36) thanin tertiary hospital; Neurology (OR: 20.38 CI: 9.65-43.06) was more likely to prescribe low-risk drugs. Consequently,tertiary hospital and neurology were more likely to prescribe low-risk drugs than clinics and internal medicine, respectively. KCI Citation Count: 0
Author 이창훈(Chang Hoon Lee), 김시인(Siin Kim), 서혜선(Hae Sun Suh)
Author_xml – sequence: 1
  fullname: 이창훈(Chang Hoon Lee), 김시인(Siin Kim), 서혜선(Hae Sun Suh)
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002552678$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNotjE1LAkEAQIcwyMw_0GkvHTrsNl87s3MU6UMQgvC-7MdsyMZuuF26hXgIETIQWkXFDoFCkJQH-0vt7H9IstO7vPf2QSGKIwnAIYIG4tSCJ7dJaGCIhMGIwQxCyA4oYmIRXVCTF0AREs51YZpsD5STpOlCwjC3ODGLwM17vbw9V9159vWs5cNUTfvqpa86Y02NO2r69rN60NRolT0N1etSzR7VbKwmqaba72q0yNNOPlxo2fJJU59ptlxsUi37WKvvNOsONt1ATdYHYDdwbhJZ_mcJNM5OG9ULvX55XqtW6nrIKNJ9GXBoyQALQSH2mYMpdjiCpiDcwqZjUkt6nHEfQZf6DnP9wPIJlp6ADoQuJyVwvN1GrcAOvaYdO80_Xsd22LIrV42azRjGDKGNe7R1w_vYjW03jkNPRneyZVOIIMScCk4YIb98a4Uj
ContentType Journal Article
Copyright COPYRIGHT(C) KYOBO BOOK CENTRE ALL RIGHTS RESERVED
Copyright_xml – notice: COPYRIGHT(C) KYOBO BOOK CENTRE ALL RIGHTS RESERVED
DBID P5Y
SSSTE
ACYCR
DOI 10.17480/psk.2019.63.6.333
DatabaseName Kyobo Scholar (교보스콜라)
Scholar(스콜라)
Korean Citation Index
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Current Status and Factors Affecting Prescription of Gastrointestinal Motility Drugs in Patients with Parkinson’s Disease
EISSN 2383-9457
EndPage 344
ExternalDocumentID oai_kci_go_kr_ARTI_6622611
4010027497363
GroupedDBID 123
9ZL
ALMA_UNASSIGNED_HOLDINGS
P2P
P5Y
SSSTE
ACYCR
ID FETCH-LOGICAL-k641-def708ef299402d6a242a7105937825a548ec767d10b4da6bdf8d32ec90a00b73
ISSN 0377-9556
IngestDate Sun Mar 09 07:51:07 EDT 2025
Thu Jun 19 02:10:28 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords nonmotor symptom
metoclopramide
Parkison’s disease
adverse event
domperidone
levosulpiride
functional dyspepsia
gastrointestinal motility drugs
Language Korean
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-k641-def708ef299402d6a242a7105937825a548ec767d10b4da6bdf8d32ec90a00b73
Notes http://www.yakhak.org/journal/view.html?uid=3117&page=&sort=&scale=10&all_k=&s_t=&s_a=&s_k=&s_v=63&s_n=6&spage=&pn=search&year=&vmd=Full
PageCount 12
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_6622611
kyobo_bookcenter_4010027497363
PublicationCentury 2000
PublicationDate 2019-12-30
PublicationDateYYYYMMDD 2019-12-30
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-30
  day: 30
PublicationDecade 2010
PublicationTitle Yaghag-hoi-ji
PublicationYear 2019
Publisher The Pharmaceutical Society Of Korea
대한약학회
Publisher_xml – name: 대한약학회
– name: The Pharmaceutical Society Of Korea
SSID ssib036278735
ssj0000615188
ssib051116396
ssib044765145
ssib001106857
Score 2.105877
Snippet Gastrointestinal motility drugs have been prescribed to manage functional dyspepsia in Parkinson’s disease(PD). However, anti-dopaminergic gastrointestinal...
SourceID nrf
kyobo
SourceType Open Website
Publisher
StartPage 333
SubjectTerms 약학
TableOfContents 서 론(Introduction) 연구 방법(Research Methods) 결 과(Results) 고 찰(Discussion) 결 론(Conclusion) 감사의 말씀(Acknowledgment) Conflict of Interest References
Title 파킨슨병 환자에서 위장관 운동조절제의 사용현황 및 처방에 미치는 요인
URI https://scholar.kyobobook.co.kr/article/detail/4010027497363
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002552678
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 약 학 회 지, 2019, 63(6), , pp.333-340
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2383-9457
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib044765145
  issn: 0377-9556
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFDddd9ll7JN1H8WMuZfUmT9kWzraaUK20a2wDLpTsGO5yQLxSNtDdxij9DBKoR0Ulpa2dIdBC4OVrYfuX1qU_2FPstKkdLAPCI4sv_f09GHpJ-vpSVEe2LSGam7M7cJooqOwFukYhkXdIklk25FHXMp3I08_dcsv0ONZZ3bkQn3IamlxIcrX3vx2X8n_1CrEQb3yXbL_ULOnQiECwlC_cIUahutf1bFWnNJwgf94wNJ8rBXh1heBQAtsjZg5_owQjYhnpKgRQwQ8GcBII4WciBI3GZHvaEVfCwBoGtkzcQMycYkLgxjf1AIhwDc0jGUARHBiSBALNq5TQfL7RGiCRSJCJZ_khJogoCTIA0uoKaJ8cqqmoPJLWiCSCYgkgnwS1NeOIJlygIfx9stwrh7O6fW0ob9q9BtXn1KwQFLBlFAo4PmwsNhvkSun8FoIKyXCW6EoDcLNQniugkFGA87yvNFo5cS51JJYFqvMcEYMMVBCFi6HFLpr6FUX6_3PMPKriymOjJALSP19ezP1M4sOfSvbZ0nuSQqAf6gjt8UyeeZAvT_qyG69cW4IsTPHIBKN2Jl3zHMDnYeEaejr-SY3TyR51867-VPWMw7EYQYtPj4Qz3btC8pFy3NdftbH9NviADibhosH69-AaqAjHwBphDzXGVp_BpQOOF46aswwj8k9-4klO5lZuUONK_rwnJowFWwupVEKiK7VToYQXeWKcllOxVQ_e6-uKiPN9JoyIct7aVKtDLYmzk-qE-rMwMv70nUl6q2t9ZYP2OpB9_sHtbfVYXsb7OMGW9lR2c4K2_v88_idyraPu-tb7NMR23_P9nfYbkdly1_Y9mGvs9LbOlS7R-sq-9bpHh0Cq9r9esJ-dLqrm8C3yXZPbiiVUrFSKOvywBK96SJTj2niGZgmgPCQYcVuCPA39PgExgYc7oQOwrTmuV5sGhGKQzeKExzbFq0RIzSMyLNvKqOttEVvKapDPQOBABejBDk0whTHjm3EJo1xzbPpmDIuyq_Kp-LcjJu2q2fqeUy5DwVbbdYaVe5Anv_PpdVmuwrT5EdVaACWa5q3_yTljnJp0PjvKqML7UV6D0D4QjQu2s8v1xW-iQ
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%ED%8C%8C%ED%82%A8%EC%8A%A8%EB%B3%91+%ED%99%98%EC%9E%90%EC%97%90%EC%84%9C+%EC%9C%84%EC%9E%A5%EA%B4%80+%EC%9A%B4%EB%8F%99%EC%A1%B0%EC%A0%88%EC%A0%9C%EC%9D%98+%EC%82%AC%EC%9A%A9%ED%98%84%ED%99%A9+%EB%B0%8F+%EC%B2%98%EB%B0%A9%EC%97%90+%EB%AF%B8%EC%B9%98%EB%8A%94+%EC%9A%94%EC%9D%B8&rft.jtitle=Yaghag-hoi-ji&rft.au=%EC%9D%B4%EC%B0%BD%ED%9B%88%28Chang+Hoon+Lee%29%2C+%EA%B9%80%EC%8B%9C%EC%9D%B8%28Siin+Kim%29%2C+%EC%84%9C%ED%98%9C%EC%84%A0%28Hae+Sun+Suh%29&rft.date=2019-12-30&rft.pub=The+Pharmaceutical+Society+Of+Korea&rft.issn=0377-9556&rft.volume=63&rft.issue=6&rft.spage=333&rft.epage=344&rft_id=info:doi/10.17480%2Fpsk.2019.63.6.333&rft.externalDocID=4010027497363
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0377-9556&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0377-9556&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0377-9556&client=summon